Myelodysplastic_Syndrome_Exome_Sequnecing
Cancer is driven by mutation. Illumina GA massively parallel sequencing technology will be applied to Agilent exome hybridisation capture libraries and total genomic paired-end libraries. Bespoke algorithms are being developed to identify the somatically acquired structural variants, point mutations, insertions and deletions in these samples. This project will give unprecedented insights into mutational processes, cellular repair pathways and gene networks associated with Myelodysplastic Syndrome development.
- Type: Other
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00001000045 | Illumina Genome Analyzer II Illumina HiSeq 2000 | 33 | |
EGAD00001000117 | Illumina Genome Analyzer II Illumina HiSeq 2000 | 152 | |
EGAD00001000283 | Illumina HiSeq 2000 | 764 |
Publications | Citations |
---|---|
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
N Engl J Med 365: 2011 1384-1395 |
778 |